Williams H J, Alarcón G S, Neuner R, Steen V D, Bulpitt K, Clegg D O, Ziminski C M, Luggen M E, Polisson R P, Willkens R F, Yarboro C, Morgan J, Egger M J, Ward J R
Cooperative Systematic Studies of the Rheumatic Diseases Program, the University of Utah School of Medicine, Salt Lake City, USA.
J Rheumatol. 1998 Feb;25(2):261-8.
To review the diagnoses after 5 years in patients who were identified within 12 months of the onset of well established and undifferentiated connective tissue diseases (CTD); to examine death rates and disease remissions in these patients.
This inception cohort of 410 patients was identified in 10 academic rheumatology practices. They had less than one year of signs and/or symptoms of CTD. Diagnoses of specific well established CTD were made using accepted diagnostic and classification criteria. The diagnoses after 5 years were determined.
Patients with well established CTD tended to remain with the original diagnosis. The progression of unexplained polyarthritis to rheumatoid arthritis occurred infrequently. Ten percent of patients with isolated Raynaud's phenomenon progressed to systemic sclerosis (SSc). The 5 year survival was over 90% in all diagnostic categories, with the exception of SSc, in which it was 64%.
Patients with a well established CTD usually continued with the same diagnosis. Patients with undifferentiated CTD tended to remain undifferentiated or to remit.
回顾确诊的和未分化的结缔组织病(CTD)发病12个月内确诊的患者5年后的诊断情况;研究这些患者的死亡率和疾病缓解情况。
在10个学术性风湿病诊疗机构中确定了这一初始队列的410例患者。他们出现CTD体征和/或症状的时间不到一年。采用公认的诊断和分类标准对确诊的特定CTD进行诊断。确定5年后的诊断情况。
确诊的CTD患者倾向于维持原诊断。无法解释的多关节炎进展为类风湿关节炎的情况很少见。孤立性雷诺现象患者中有10%进展为系统性硬化症(SSc)。除SSc患者5年生存率为64%外,所有诊断类别的5年生存率均超过90%。
确诊的CTD患者通常维持原诊断。未分化CTD患者倾向于维持未分化状态或病情缓解。